it is a research-literature review of a research-only compound
It may trigger a secondary tumor risk, though
Similar steps were followed for the iNeurons lysate treated with DMSO, PR619, or Bortezomib, except that RFU was calculated from the difference between the activity of protein lysates in the presence and absence of fluorogenic peptides
Peer review Peer review information Nature Medicine thanks John Wilding and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Parallel blood aliquots from healthy controls were analyzed using the NADMED assay and two in-house MS methods: LC-MS NADomics 35 and targeted MS-Omics 36
M., Graham, C., & OHare, A